Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Other Operating Expenses data on file, last reported at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 13.5% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $7.6 billion (down 13.3% YoY), and the FY2025 full-year result was $7.8 billion, down 48.01% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $1.6 billion, down from $2.6 billion in the prior quarter.
• Across five years, Other Operating Expenses topped out at $8.1 billion in Q1 2024 and bottomed at $1.6 billion in Q1 2026.
• The 5-year median for Other Operating Expenses is $1.8 billion (2025), against an average of $2.5 billion.
• The widest annual swing landed in 2024, when Other Operating Expenses soared 331.31%; it then tumbled 77.9% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $3.2 billion in 2022, then dropped by 21.53% to $2.5 billion in 2023, then plunged by 36.89% to $1.6 billion in 2024, then surged by 63.35% to $2.6 billion in 2025, then plunged by 39.48% to $1.6 billion in 2026.
• The last three Other Operating Expenses figures came in at $1.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.

Peer Comparison